Corporate Overview Presentation February 2026 2026 Vir Biotechnology, Inc. 1 Legal disclaimer Forward-Looking Statements Statements in this presentation that are not statements of historical fact are forward-looking statements. Such forward-looking statements include, without limitation, statements regarding: the therapeutic and commercial potential of Vir Biotechnology's CHD program, as well as Vir Biotechnology's strategy, plans and expectations related thereto; the therapeutic and commercial potential of ...

Core Viewpoint - V2X, Inc. will report its fourth quarter and full year 2025 financial results on February 23, 2026, after market close, followed by a conference call with senior management [1]. Financial Results Announcement - The financial results will be disclosed on February 23, 2026, after market close [1]. - A conference call is scheduled for 4:30 p.m. ET on the same day [1]. Conference Call Details - U.S.-based participants can dial in at 877-300-8521, while international participants can call 412-317-6026 [2]. - A live webcast and accompanying slide presentation will be available on the V2X website [2]. Replay Information - A replay of the conference call will be available on the V2X website shortly after the call and will remain accessible for one year [3]. - Telephonic replay will be available until March 9, 2026, at 844-512-2921 (domestic) or 412-317-6671 (international) with passcode 10206521 [3]. Company Overview - V2X builds innovative solutions that integrate physical and digital environments, enhancing readiness and optimizing resource management [4]. - The company operates across national security, defense, civilian, and international markets, employing approximately 16,000 professionals [4]. - V2X leverages AI and machine learning capabilities to address challenges across all operational domains [4].

Core Insights - The company is experiencing double-digit revenue growth across various products and geographies, driven by diversification and improved operational efficiency through AI and machine learning [1][2][12] - The December quarter showed strong business momentum, with revenue reaching $151.4 million, a 12% year-over-year increase, and EBITDA of $39 million, reflecting a 76% year-over-year growth [2][14] - The company has made significant progress in strengthening its balance sheet, reducing its debt leverage ratio from over five turns to approximately three turns [5][19] Revenue and Growth - Total revenue for the fiscal third quarter was $151.4 million, with the On Device Solutions (ODS) segment generating $99.6 million (up 9% year-over-year) and the Application Growth Platform (AGP) segment contributing $52.6 million (up 19% year-over-year) [14][15] - The international business is a key growth driver, with over 30% of revenues from the Ignite platform coming from outside the U.S. and a greater than 20% increase in both devices and revenue per device [6][5] Operational Efficiency - The company reported a gross profit increase of over 25% while operating expenses declined, showcasing improved operational efficiency [1] - Cash operating expenses were down 4% year-over-year, contributing to a non-GAAP gross margin of 49%, up from 44% in the prior year [16] Strategic Priorities - The company has identified five strategic priorities to sustain growth, including leveraging first-party data, enhancing the flywheel effect between supply and demand, scaling the brand business, expanding services through the Ignite platform, and exploring alternative app opportunities [9][10][11] - The integration of technology stacks has allowed the company to better utilize first-party data and AI capabilities, driving growth in both segments [15][12] Financial Performance - Adjusted EBITDA for the fiscal third quarter totaled $38.8 million, representing a 76% increase year-over-year, with an EBITDA margin of 26% [15][16] - The company ended the quarter with a cash balance of $40 million and reduced total debt by over $41 million, resulting in a stronger balance sheet [18][19] Future Outlook - Following strong performance in December, the company has raised its full-year revenue guidance to a range of $553 million to $558 million and adjusted EBITDA guidance to $114 million to $117 million for fiscal year 2026 [20]

Core Viewpoint - Itron, Inc. (ITRI) has experienced a significant decline in its stock price, dropping 26% over the past three months and 31.6% over the past six months, underperforming both the Zacks Electronics - Testing Equipment industry and the broader market [1][8]. Financial Performance - Itron has lowered its 2025 revenue guidance to $2.35–$2.36 billion, indicating an approximate 3% year-over-year decline. The fourth-quarter 2025 revenue is projected to be between $555–$565 million, reflecting a 9% decrease from the previous year [4]. - Non-GAAP EPS is expected to range from $2.15 to $2.25 [4]. Competitive Landscape - The company is facing intense competition, leading to pricing pressure and potential market share erosion. Macroeconomic uncertainties, including higher interest rates and inflation, are causing consumers to delay bill payments and impacting project approvals [3][4]. Operational Challenges - Itron's elevated debt burden stands at $1.265 billion, with a debt-to-capital ratio of 42.1%, significantly higher than the industry average of 25.8%. This high leverage may limit cash flow flexibility and access to favorable refinancing options [5]. Growth Drivers - Despite the challenges, Itron's Grid Edge Intelligence platform is showing momentum, driven by demand in data centers, electrification, grid modernization, and digitalization across utilities, supported by a backlog of $4.3 billion [6]. - Frequent product launches, including the Gen6 network platform and UtilityIQ suite, are enhancing Itron's offerings and market position [9]. Strategic Initiatives - Itron is pursuing strategic acquisitions, such as the planned acquisition of Locusview for $525 million and Urbint, Inc. for $325 million, aimed at enhancing its capabilities in utility construction management and predictive risk analytics [10]. - Collaborations with companies like Gordian Technologies to integrate AI and machine learning into its offerings are expected to improve grid resilience and operational efficiency [10]. Valuation - Itron's stock is currently trading at a forward 12-month Price/Earnings ratio of 13.54X, which is below the industry average of 23.84X, indicating a potential undervaluation [11].

Core Insights - V2X, Inc. has been awarded a $72 million contract to provide support and engineering services for the Gateway Mission Router (GMR) [1] - The GMR is designed to enhance air-to-ground operations and adapt to evolving mission needs through open-standard interfaces, enabling a unified common operating picture [2] - The system supports the Department of Defense's Combined Joint All Domain Command and Control initiative, aiming for faster, data-driven decision-making across multiple domains [3] Company Developments - The contract represents a significant milestone for V2X as it continues to advance the GMR program and expand its applications within the U.S. military [4] - This new contract builds upon a previous $49 million contract, indicating ongoing investment and growth potential in the GMR program [4] - The estimated completion date for the current contract is June 25, 2030, highlighting a long-term commitment to the project [4] Company Overview - V2X specializes in integrating physical and digital environments to enhance mission readiness, optimize resource management, and improve security [5] - The company employs approximately 16,000 professionals and focuses on innovation across national security, defense, civilian, and international markets [5] - V2X incorporates AI and machine learning capabilities to address complex challenges across various operational domains [5]

Company Overview - CoreWeave Inc. is a U.S. company that provides high-performance, GPU-based cloud infrastructure specifically for AI and machine learning [3] Allegations and Stock Impact - Edelson Lechtzin LLP is investigating CoreWeave for potential violations of federal securities laws due to allegations of misleading business information [1] - On November 10, 2025, CoreWeave announced a reduction in its full-year 2025 revenue and capital expenditure forecasts, citing limitations on data center capacity [4] - Following this announcement, CoreWeave's stock price dropped by $17.22 per share, or 16.31%, closing at $88.30 per share on November 11, 2025 [4]

Core Viewpoint - Tempus AI, Inc. reported strong third-quarter FY25 earnings, leading to a reiterated Buy rating from BTIG analyst Mark Massaro with a price target of $96, despite current selling pressure on the stock [1]. Earnings Details - Tempus AI reported revenue of $334.21 million, exceeding analyst estimates of $328.73 million, representing an 84.7% year-over-year increase [2]. - The adjusted loss per share was 11 cents, better than the estimated loss of 17 cents [2]. - For FY25, the company raised its revenue guidance to $1.265 billion from a previous estimate of $1.260 billion [2]. Analyst View - The analyst anticipates that Tempus will secure additional pharmaceutical contracts for its data and services business [3]. - There is an expectation for average selling prices (ASPs) to increase due to a shift towards higher-priced tests, such as the xT CDx priced at $4,500 per test (up from $2,900 for xT LDT) and the xF liquid biopsy assay at $3,288 per test (up from $2,919) [3]. - Expansion of commercial payor coverage for xF and xT CDx is expected, along with continued development of Tempus's algorithm business [3]. Market Positioning - Tempus is positioned at the intersection of key trends including precision medicine, oncology (including liquid biopsies), AI and machine learning, and the shift towards personalized drug development and companion diagnostics for pharmaceutical companies [4]. - As of the publication date, Tempus shares were down 2.74% at $82.18 [4].

Financial Data and Key Metrics Changes - Q3 net sales reached $110.3 million, representing a year-over-year increase of 10.4%, exceeding the top end of guidance by approximately 40 basis points [17] - Adjusted EBITDA for Q3 was $3.6 million, with an adjusted EBITDA margin of 3.2%, marking the 17th consecutive quarter of positive adjusted EBITDA [18] - Gross margin for Q3 was 57.6%, within the medium-term target range, but a decline of 320 basis points compared to Q3 last year [18] - Average order value (AOV) was $2,209, reflecting a decline of 5.5% year-over-year but an increase of 6.5% quarter-over-quarter [17] Business Line Data and Key Metrics Changes - Engagement ring bookings returned to growth, marking an inflection point after a multi-year market normalization [9] - Wedding and anniversary band bookings achieved the largest quarter ever, with double-digit year-over-year growth [10] - Fine jewelry bookings grew 45% year-over-year, driven by both unit and average selling price (ASP) growth [11] Market Data and Key Metrics Changes - Total orders grew 17% year-over-year, while repeat orders increased by 16% year-over-year, indicating strong brand resonance [9] - The company noted stabilization in engagement ring average selling prices, with sequential ASP growth in the last two quarters [9] Company Strategy and Development Direction - The company aims to continue capturing market share in the $350 billion jewelry industry, leveraging its asset-light, data-driven business model [5] - Strategic brand investments and celebrity placements have significantly increased brand awareness, generating over 13 billion impressions in Q3 [12] - The company is focused on expanding its showroom footprint and enhancing its omnichannel shopping experience [40] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating industry-wide headwinds such as rising metal prices and tariffs, citing a globally diversified supply chain as a competitive advantage [24] - The company raised its full-year net sales guidance to 3-4.5% growth year-over-year, driven by improvements in engagement ring bookings and strong fine jewelry performance [22] - Management anticipates some impact from gold and platinum prices in Q4, which are near all-time highs, and the additional 25% tariff on India [24] Other Important Information - The company ended Q3 with approximately $73 million in cash and has generated approximately $12 million of free cash flow on a trailing 12-month basis [21] - The company has no debt on its balance sheet and has spent approximately $1.1 million on stock repurchases to date [22] Q&A Session Summary Question: Sustainability of engagement ring bookings growth and expectations for bridal recovery versus fine jewelry mix - Management is optimistic about the sustainability of engagement ring bookings growth and expects to continue outperforming the industry [26] Question: Adjusted EBITDA margin guidance and impact of metals pricing and tariffs - Management indicated that they have taken selective pricing increases and are continuously optimizing pricing to mitigate cost increases [28] Question: Top-line guidance for the full year and headwinds - Management noted that the top-line guidance factors in strong performance in engagement and fine jewelry, with caution due to the holiday season's variability [33] Question: Marketing efficiencies driving sales and leverage - Management highlighted improvements in marketing efficiency through better allocation of spend and machine learning models to enhance site conversion [37] Question: Capital priorities and factors driving upside in fine versus engagement jewelry - Management emphasized a strong balance sheet and flexibility to invest in showroom expansion and brand awareness while maintaining a focus on ROI [40]

Financial Data and Key Metrics Changes - Total revenue grew 25% to $755 million, driven by 15% organic growth and nearly 10% from M&A [3][27][28] - Adjusted EBITDA increased 23.8% to $236 million, with an adjusted EBITDA margin of 31.2%, slightly down from 31.5% in the prior year [3][27][28] - Adjusted earnings per share rose 14.6% to $0.47 [3][28] Business Line Data and Key Metrics Changes - The casualty business showed strong growth across all specialties, with high renewal retention and new business generation [4][19] - Property business returned to growth, driven by new business and high renewal retention, despite ongoing pricing pressures [18][19] - Underwriting management specialty grew significantly, with contributions from recent acquisitions adding over 30% to top-line growth [23][27] Market Data and Key Metrics Changes - The company noted a steady flow of business into the E&S channel, which helped maintain organic growth despite property pricing headwinds [24][32] - The property market is expected to face continued deterioration in pricing, with anticipated rate reductions of 20% to 30% [39][32] Company Strategy and Development Direction - The company is focused on strategic investments in talent, technology, and innovative products to drive long-term growth [5][6][30] - A commitment to M&A remains a top priority, with a robust pipeline for future acquisitions [28][25] - The company is deferring its 2027 target for a 35% adjusted EBITDA margin to prioritize growth opportunities [14][31] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving double-digit organic growth for 2025, marking the 15th consecutive year of such growth [7][30] - The company is optimistic about sustaining similar growth levels into 2026, despite potential market challenges [8][30] - Management highlighted the importance of recruiting and retaining top talent as a key driver for future success [6][16] Other Important Information - The company launched Ryan Alternative Capital Re, a collateralized sidecar to enhance its underwriting capacity [23] - Recent leadership changes were announced, with new Co-Presidents appointed to drive operational excellence and client impact [8][9] Q&A Session Summary Question: Can you unpack the 15% organic growth? - Management indicated that the growth was driven by submission growth, new business, and high renewal retention across all specialties [33][35] Question: How sustainable is the organic revenue growth in underwriting management? - Management expects continued double-digit organic growth in underwriting management, fueled by capital markets activity and strategic investments [50] Question: Will the current market environment influence talent investment decisions? - Yes, the company adjusts its talent investment strategy based on market conditions, focusing on areas with growth potential [51] Question: What are the expectations for margin improvement in 2026? - Management anticipates continued margin pressures in 2026 due to ongoing investments in talent, but modest margin expansion is expected in the long term [45][59] Question: How does the company view the current dynamics in the London specialty marketplace? - The company is revisiting its strategy in London, focusing on improving offerings and addressing potential conflicts [60]

Company Overview - V2X, Inc. is a leading provider of global mission solutions, focusing on integrating physical and digital environments to enhance mission readiness and security [4]. Financial Results Announcement - V2X will report its third quarter 2025 financial results on November 3, 2025, after market close [1]. - A conference call will be held at 4:30 p.m. ET on the same day to discuss the results [1]. Conference Call Details - U.S.-based participants can join the conference call by dialing 877-300-8521, while international participants can call 412-317-6026 [2]. - A live webcast and accompanying slide presentation will be available on the V2X website [2]. Replay Information - A replay of the conference call will be accessible on the V2X website for one year following the call [3]. - Telephonic replay will be available until November 17, 2025, with specific numbers for domestic and international callers [3].